Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/52486
Title: Gene expression changes in Brodmann's Area 46 differentiate epidermal growth factor and immune system interactions in schizophrenia and mood disorders.
Authors: Ketharanathan T.;Pereira A.;Sundram S. 
Monash Health Department(s): Mental Health
Institution: (Ketharanathan, Pereira) The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC 3052, Australia
(Ketharanathan, Pereira) Department of Psychiatry, University of Melbourne, Parkville, VIC 3052, Australia
(Ketharanathan) Northern Health, Epping, VIC 3076, Australia
(Sundram) Department of Psychiatry, School of Clinical Sciences, Monash University, Clayton, VIC 3168, Australia
(Sundram) Mental Health Program, Monash Health, Clayton, VIC 3168, Australia
Issue Date: 10-Sep-2024
Copyright year: 2024
Publisher: Nature Research
Place of publication: United Kingdom
Publication information: Schizophrenia. 10(1) (no pagination), 2024. Article Number: 76. Date of Publication: December 2024.
Journal: Schizophrenia
Abstract: How early in life stress-immune related environmental factors increase risk predisposition to schizophrenia remains unknown. We examined if pro-inflammatory changes perturb the brain epidermal growth factor (EGF) system, a system critical for neurodevelopment and mature CNS functions including synaptic plasticity. We quantified genes from key EGF and immune system pathways for mRNA levels and eight immune proteins in post-mortem dorsolateral prefrontal (DLPFC; Brodmann's Area (BA) 46) and orbitofrontal (OFC; BA11) cortices from people with schizophrenia, mood disorders and neurotypical controls. In BA46, 64 genes were differentially expressed, predominantly in schizophrenia, where attenuated expression of the MAPK-ERK, NRG1-PI3K-AKT and mTOR cascades indicated reduced EGF system signalling, and similarly diminished immune molecular expression, notably in TLR, TNF and complement pathways, along with low NF-kappaB1 and elevated IL12RB2 protein levels were noted. There was nominal evidence for altered convergence between ErbB-PI3K-AKT-mTOR and TLR pathways in BA46 in schizophrenia. Comparatively minimal changes were noted in BA11. Overall, distinct pathway gene expression changes may reflect variant pathological processes involving immune and EGF system signalling between schizophrenia and mood disorder, particularly in DLPFC. Further, the abnormal convergence between innate immune signalling and candidate EGF signalling pathways may indicate a pathologically important interaction in the developing brain in response to environmental stressors.Copyright © The Author(s) 2024.
DOI: http://monash.idm.oclc.org/login?url=https://dx.doi.org/10.1038/s41537-024-00488-8
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/52486
Type: Article
Subjects: mood disorder
schizophrenia
Appears in Collections:Articles

Show full item record

Page view(s)

2
checked on Sep 18, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.